RESHAPE LIFESCIENCES INC (RSLS)

US76090R2004 - Common Stock

4.38  -0.09 (-2.01%)

RESHAPE LIFESCIENCES INC

NASDAQ:RSLS (12/20/2024, 8:00:01 PM)

4.38

-0.09 (-2.01%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS SubIndustryHealth Care Equipment
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-204.61%
Sales Q2Q%6.36%
CRS4.09
6 Month-61.33%
Overview
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Ins Owners26.67%
Inst Owners81.7%
Market Cap3.11M
Shares710.00K
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts43.33
Short Float %3.5%
Short Ratio0.23
IPO10-06 2016-10-06
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

RSLS Daily chart

Company Profile

ReShape Lifesciences Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in San Clemente, California and currently employs 31 full-time employees. The company went IPO on 2016-10-06. ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The firm offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Company Info

RESHAPE LIFESCIENCES INC

1001 Calle Amanecer

San Clemente CALIFORNIA 92673

P: 19494296680

CEO: Andrew Rasdal

Employees: 29

Website: https://www.reshapelifesciences.com/obalon/

RSLS News

News Imagea month ago - ReShape Lifesciences IncReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
News Imagea month ago - ReShape Lifesciences IncReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update

Revenue Increased 16.6% in the Third Quarter of 2024 Over the Second Quarter, Representing the Third Sequential Quarter of Growth, and 6.4% Compared to the...

News Imagea month ago - ReShape Lifesciences IncReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

Conference Call to be Held at 4:30 pm ET on Thursday, November 14, 2024

News Imagea month ago - ReShape Lifesciences IncReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

Conference Call to be Held at 4:30 pm ET on Thursday, November 14, 2024...

News Imagea month ago - ReShape Lifesciences IncReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

FLEX Technology Designed to Improve the Patient Experience

News Imagea month ago - ReShape Lifesciences IncReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX

FLEX Technology Designed to Improve the Patient Experience...

RSLS Twits

Here you can normally see the latest stock twits on RSLS, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example